ASPPH logo


Member Research & Reports

Member Research & Reports

Johns Hopkins: Prescriptions for Opioid Use Disorder Treatment, Opioid Pain Relievers After ACA Medicaid Expansion

Medicaid expansion under the Affordable Care Act (ACA) was associated with an overall increase in people filling prescriptions for buprenorphine with naloxone, which is a treatment for opioid use disorder, as well as an increase in people filling prescriptions for opioid pain relievers (OPRs) paid for by Medicaid in a data analysis from five states, according to a new study in JAMA Network Open by Dr. Brendan Saloner, assistant professor in the department of health policy and management at the Johns Hopkins Bloomberg School of Public Health.

This study used pharmacy claims data for five states (three that expanded Medicaid and two that didn’t) to examine changes in prescriptions filled for buprenorphine with naloxone and for opioid pain relievers after the ACA’s Medicaid expansion: 11.9 million individuals who filled two or more prescriptions for opioids during at least one year between 2010 and 2015 from California, Maryland, and Washington (Medicaid expansion states) and Florida and Georgia (non-expansion states)

In the five states where data were analyzed, Medicaid expansion was:

Read more